Hot Topics in Health
NCL recently presented the Food and Drug Administration with a sampling of key findings from research conducted to explore consumer perceptions and attitudes about an over-the-counter cholesterol-lowering drug as an option for those with moderately high cholesterol.
Consumers today are taking a more active role in their health care and self-diagnosing and self-medicating with over the counter medications, as well as dietary supplements and herbals. Historically NCL has been in favor of a "behind-the-counter" drug class to increase patient access to those medications they can safely use, after consultation with a pharmacist, to self-treat conditions they can self-diagnose. A BTC class would expand the range of conditions that patients can self-treat without spending time or money on a doctor’s visit. NCL's Rebecca Burkholder recently testified before the Food and Drug Administration about why and how NCL would support a new BTC class of drugs.
The National Consumers League has sent a letter to Congressional leaders expressing concerns with the current generic biologics language included in the health reform package. Improving access to life-savings medicines must remain the top priority at this historic moment of healthcare reform, and the current biologics language, which would grant an unprecedented 12-year period of monopoly protection to the most expensive medicines, falls short of that goal.